Akums Drugs moves up as its arm starts second production facility at Haridwar manufacturing unit
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
Akums Drugs & Pharmaceuticals is currently trading at Rs. 961.40, up by 1.95 points or 0.20% from its previous closing of Rs. 959.45 on the BSE.
The scrip opened at Rs. 971.00 and has touched a high and low of Rs. 1007.40 and Rs. 941.60 respectively. So far 67616 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 1174.85 on 20-Aug-2024 and a 52 week low of Rs. 724.50 on 06-Aug-2024.
Last one week high and low of the scrip stood at Rs. 1174.85 and Rs. 941.60 respectively. The current market cap of the company is Rs. 15330.17 crore.
The promoters holding in the company stood at 84.91%, while Non-Institutions held 15.09% stake in the company.
Akums Drugs and Pharmaceutical’s wholly owned subsidiary -- Akums Healthcare has commenced its second production facility on August 22, 2024 for manufacturing of eye/ear drops, injectable & infusions dosage forms at its manufacturing unit located at Haridwar, Uttarakhand.
Akums Drugs and Pharmaceuticals is a pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of pharmaceutical products and services in India and overseas.
